| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.700 | None | 0.952 | 2 | 0 | 1989 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.957 | 4 | 0 | 1979 | 2020 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 1976 | 2020 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
lecithin-cholesterol acyltransferase | 0.588 | 0.654 | 8.1E-02 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1987 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2005 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.060 | None | 1.000 | 2 | 0 | 2004 | 2018 | ||||||||
|
solute carrier family 2 member 4 | 0.528 | 0.769 | 4.7E-05 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2012 | ||||||||
|
upstream transcription factor 1 | 0.592 | 0.692 | 2.4E-02 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2001 | 2020 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
nicotinamide phosphoribosyltransferase | 0.502 | 0.808 | 0.98 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
cytochrome P450 family 7 subfamily A member 1 | 0.576 | 0.615 | 2.5E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
carboxypeptidase E | 0.584 | 0.692 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
acyl-CoA synthetase long chain family member 3 | 0.674 | 0.538 | 3.5E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
acyl-CoA synthetase long chain family member 5 | 0.641 | 0.500 | 2.9E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
oncostatin M | 0.505 | 0.769 | 0.59 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |